We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Local time in host city

Programme

Search
Filters
72 Sessions
Monday
May 05
17:00 - 18:00
Strauss 3
Quiz and Young Researcher Award
Morten Horsholt Kristensen, Denmark
Young Networking Session
Young
Monday
May 05
17:00 - 18:00
Stolz 1
Breast 2
Annett Linge, Germany;
Elisabetta Bonzano, Italy
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
Breast
Monday
May 05
17:00 - 18:00
Business 1-2
Toxicity and outcome prediction
Eva Onjukka, Sweden;
Xuanfeng Ding, USA
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Physics
Monday
May 05
17:00 - 18:00
Stolz 2
How to strategically advance radiation oncology in the future
Cai Grau, Denmark;
Yavuz Anacak, Turkey
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Interdisciplinary
Monday
May 05
17:00 - 18:00
Business 3-4
Gynaecological 3
Alina Sturdza, Austria;
Federico Mastroleo, Italy
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Gynaecology
Monday
May 05
18:15 - 19:15
Mahler
General assembly
Assembly
Interdisciplinary
Dosimetry & QA / FLASH
Tuesday
May 06
08:30 - 09:10
Mahler
Transforming radiotherapy by spatially-fractionated radiotherapy
Federico Iori, Italy
Spatially Fractionated Radiation Therapy (SFRT) encompasses a group of irradiation techniques that utilize a non-uniform dose distribution to enhance the response of large tumors, minimize damage to surrounding healthy tissues, and stimulate the host immune system against neoplastic cells. Despite the limited evidence, clinical experiences have demonstrated remarkable results, sparking renewed interest in SFRT applications. During this session, attendees will receive an overview of SFRT techniques, along with valuable insights for their clinical practice. Specifically, Prof. Slavisa Tubin will explore the radiobiological rationale and the clinical evidence of SFRT, while Dr. Natalia Tejedor Aguilar will address treatment planning and technical aspects.
Teaching Lecture
Interdisciplinary
Spatially fractionnated RT / Urology
Tuesday
May 06
08:30 - 09:15
Brahms
AI in radiation oncology education
Pierfrancesco Franco, Italy
Teaching Lecture
Interdisciplinary
Breast
Tuesday
May 06
08:30 - 09:10
Strauss 1-2
Neoadjuvant therapy and non-operative management for oesophago-gastric cancer: Where do we stand?
Cihan Gani, Germany
Teaching Lecture
Clinical
GI
Tuesday
May 06
08:30 - 09:10
Schubert
Explainability and interpretability in AI
Jennifer Dhont, Belgium
Teaching Lecture
Physics
AI in RT
Tuesday
May 06
08:30 - 09:10
Lehar 1-3
Back to the future: Electron treatments today and tomorrow
Fabio D'Andrea, United Kingdom;
Jenny Bertholet, Switzerland
Pitch Session
Physics
Dosimetry & QA / FLASH
Tuesday
May 06
08:30 - 09:10
Haydn
Veterinary radiotherapy: The why, when, and how?
Elizabeth Denney, Switzerland
Teaching Lecture
RTT
Tuesday
May 06
08:30 - 09:10
Strauss 3
Are we ready for hypofractionation in soft tissue sarcomas?
Nicolaus Andratschke, Switzerland
Panel Discussion
Clinical
Soft Tissue
Tuesday
May 06
09:15 - 10:30
Mahler
Innovation in healthcare: Who pays?
Mark Gooding, United Kingdom
Drawing from the spirit of ESTRO’s theme 'Transformative innovation through partnership', we will explore how innovation is financed, whether academically or commercially, through to the point of use in the clinic. By considering the cost of research and development and outlining the funding that is required, we will better understand how money flows through the system and appreciate the role each participant has as we collaborate to improve patient care. Short presentations by the various stakeholders in the innovation pipeline will be followed by a panel discussion, giving substantial time to questions from the floor.
Panel Discussion
Interdisciplinary
Tuesday
May 06
09:15 - 10:30
Brahms
Climate change and cancer: How are they connected?
Azadeh Abravan, United Kingdom;
Kari Tanderup, Denmark
Will climate change impact cancer care? How big is the carbon footprint from radiotherapy? What can I do to make radiotherapy more sustainable? If you think these questions are important, we welcome you to join this symposium to get more insights. You will learn about potential disruptions in radiotherapy treatment continuity caused by extreme weather events and their potential effects on patient outcome. Also, health care – including radiotherapy – is a source of carbon footprint. This symposium will give you an overview of the most important contributors to the radiotherapy carbon footprint as well as an introduction to effective mitigations strategies. Finally, there will be a discussion about why and how the healthcare system can transform towards sustainability – e.g. through value-based healthcare, innovative solutions, research and education.
Symposium
Interdisciplinary
Tuesday
May 06
09:15 - 10:30
Strauss 1-2
Joint ESTRO-ASTRO: Kidney cancer and stereotactic body radiotherapy: Potential areas of implementation and improvement
Howard Sandler, USA;
Stephane Supiot, France
Symposium
Clinical
Urology
Tuesday
May 06
09:15 - 10:30
Schubert
Novel approaches to AI in radiation oncology
Laia Humbert-Vidan, USA;
Stine Korreman, Denmark
Artificial intelligence is transforming radiation oncology, driving advances in fields such as medical imaging, tumor segmentation, and decision support. This session brings together experts at the forefront of AI applications, showcasing the latest innovations in these fields. Kareem Abdul Wahid will open the session with insights into how data science competitions accelerate AI advancements in radiation oncology, with a focus on the HNTS-MRG 2024 Challenge for MRI-guided tumor segmentation. He will discuss how benchmarking competitions accelerate the development of deep learning models, highlighting key takeaways on architecture choices, ensembling strategies, and training methodologies. Matteo Maspero will then explore the role of physics-informed neural networks (PINNs) in synthetic CT (sCT) generation from MRI. He will explain how incorporating physical priors enhances AI model performance, discuss applications in quantitative MRI and radiotherapy planning, and examine future potential for expanding physics-informed models in medical imaging. Expanding the discussion to broader applications, Ana Maria Barragan Montero will provide a comprehensive overview of foundation models in radiotherapy, discussing their advantages over traditional architectures like UNet. She will explore applications in medical imaging, multimodal models, and address critical challenges in model trustworthiness, reliability, and sustainability. Finally, Florian Putz will showcase the emerging role of large language models (LLMs) in radiation oncology, from decision support and automated documentation to multimodal AI-powered research tools. He will highlight LLM integration with oncology information systems, workflow automation, and privacy-preserving AI solutions for clinical applications. This symposium provides a cohesive journey from data-driven AI innovations to foundational AI principles and real-world clinical applications. Attendees will gain a comprehensive understanding of how the latest AI advancements are transforming radiation oncology and shaping its future.
Symposium
Physics
AI in RT
Tuesday
May 06
09:15 - 10:30
Lehar 1-3
Joint ESTRO-AAPM: Re-irradiation revolution: Maximising technical advances in imaging, biology and dose evaluation
Charles Mayo, USA;
Núria Jornet, Spain
Symposium
Physics
Breast / Dosimetry & QA / Lung / Reirradiation / Soft Tissue
Tuesday
May 06
09:15 - 10:30
Haydn
RTT scope of practice: Current landscape and career opportunities
Erica Bennett, Ireland
The role of the radiation therapist (RTT) is continually evolving with technological developments and in response to the complexities of care that cancer patients need and deserve. Combined treatment regimens and the ability to safely escalate radiation doses means the patient pathway requires multidisciplinary expertise. This session reviews our RTT changing scope of practice and how we, as experts in our field, can drive our professional development and recognition. The transformation from a newly graduated clinical RTT to roles that encompass expanded and advanced practice requires knowledge, personal growth, support and leadership. The 4 speakers will share insights into our evolving scope covering applications in management, research, and explore opportunities for the future direction of our RTT practice. This engaging session will be interactive: the audience are encouraged to ask questions and share their own experiences within the panel discussion.
Panel Discussion
RTT
Tuesday
May 06
09:15 - 10:30
Strauss 3
Evidence-based palliative radiotherapy: Accommodating patient-needs
Izabela Zarębska, Poland;
Mateusz Spałek, Poland
This symposium will explore the critical role of radiotherapy in palliative oncology care. Topics will focus on the potential and challenges of radiotherapy in the end-of-life care in the context of clinical trials. In addition, speakers will dive into the literature and discuss the interplay between palliative radiotherapy and immunotherapy. This session will include an insight in the advances in techniques and technologies in the setting of palliative radiotherapy as well as value-based healthcare. Finally, we will discuss the results of the BONY-M trial. This is a must-attend session that will provide a state-of-the-art overview of patient-centered management of advanced cancer.
Symposium
Clinical
Tuesday
May 06
11:00 - 12:15
Mahler
Crossing the 2nd translational gap in radiation oncology: How do we ensure innovation gets to patients and delivers the best possible outcomes
Konrad Stawiski, Poland;
Uulke van der Heide, The Netherlands
Quality improvement in radiation oncology is driven by balancing tumor control, side effects and quality of life. In this symposium four lectures will address the fundamentals of implementation science and discuss how randomized trials can be used as a tool to improve radiotherapy and implement quality assurance programs. To improve quality in radiotherapy, lessons can be learned from Lean thinking as introduced first in the car industry. The final presentation will address the new financial reality for health care spending globally and build the case for investing in radiotherapy.
Symposium
Interdisciplinary
Tuesday
May 06
11:00 - 12:15
Brahms
Best practices in patient involvement: A win-win for cancer societies and patients
Aleksandra Napieralska , Poland;
Barbara Alicja Jereczek-Fossa, Italy
Symposium
Interdisciplinary
Breast
Tuesday
May 06
11:00 - 12:15
Strauss 1-2
Bladder cancer: Status quo and areas of improvement
Giulio Francolini, Italy;
Wojciech Kamzol, Poland
Symposium
Clinical
Urology
Tuesday
May 06
11:00 - 12:15
Schubert
Is it time to move from fixed volume-based to probabilistic map-based treatment planning?
Kristoffer Moos, Denmark;
Robert Jeraj, Slovenia
Symposium
Physics
SBRT
Tuesday
May 06
11:00 - 12:15
Lehar 1-3
Stacking it high: Treatment planning in the presence of existing dose for ART, brachytherapy, boosting, and reirradiation
Christoph Bert, Germany;
Lucy van Werkhoven, The Netherlands
Summation of doses is required in several treatments of radiation oncology. The Symposium will give an overview for some of these namely combined treatment of brachytherapy and photons, the setting of re-irradiation, and adaptation. These speakers will each introduce the relevant issues, the current procedures in daily clinical practice incl. the main methods/tools in use. An overarching topic is deformable image registration software, which is needed in each case. Current advances, assessment of uncertainties and an outlook on registration approaches will wrap up the session.
Symposium
Physics
Dosimetry & QA / GI / Gynaecology / Reirradiation
Tuesday
May 06
11:00 - 12:15
Haydn
Joint ESTRO-IAEA: RTT workforce recruitment and retention strategies
Elena Fidarova, Austria;
Philipp Scherer, Austria
Highly skilled and sufficient workforce is crucial for quality and safe radiotherapy, but many regions of the world are facing staff shortages due to various reasons. RTTs are particularly affected, especially because in many countries worldwide, the profession of RTT is not recognised and there is lack of education and training programmes. Therefore, comprehensive and innovative workforce recruitment and retention strategies are of paramount importance. Moreover, targeted interventions at workplace aimed at enhancing job satisfaction, resilience, mental and physical health are vital components in reducing staff turnover and ensuring service continuity. The speakers in this session will discuss existing challenges and share best practices and solutions, mainly within the context of European region.
Pitch Session
RTT
Tuesday
May 06
11:00 - 12:15
Strauss 3
Joint ESTRO-EANM-CIRSE: Transforming radiotherapy by radioligand therapy and interventional radiology
Felix Mottaghy, Germany;
Philippe Pereira, Germany;
Stefanie Corradini, Germany
Symposium
Clinical
Tuesday
May 06
12:25 - 13:30
Strauss 1-2
Closing Session - The European Radiation Oncology Moonshot Cancer Programme
Anna Kirby, United Kingdom;
Barbara Alicja Jereczek-Fossa, Italy;
Matthias Guckenberger, Switzerland
The US government has launched the Cancer Moonshot program in 2016, aiming to “reduce the cancer death rate by half within 25 years and improve the lives of people with cancer and cancer survivors.” The program emphasis, that it “invests heavily in opportunities to speed delivery of cancer drugs and vaccines to prevent and treat cancer”. Radiation Oncology or Radiotherapy are not mentioned. In this debate, we will hear four proposals from four esteemed colleagues, describing a Cancer Moonshot program for Radiation Oncology, following ESTRO`s vision “Optimal Health for All”. The programs aim at transformative breakthroughs in Radiation Oncology, to substantially reduce cancer death rate and improve quality of life. The esteemed colleagues have a different professional background – one Radiation Oncologist, one medical Physicist, one Radiobiologist and one RTT. However, it is obvious that such an ambitious goal can only be achieved together, including our ESTRO society. All colleagues aim to convince the ESTRO conference participants to dedicate one Billion Euros over a period of 15 years to realize their vision of a Radiation Oncology Cancer Moonshot program.
Debate
Interdisciplinary
Breast / Dosimetry & QA / SBRT / Urology
Breast
Digital Poster
Brachytherapy
Gastro-intestinal, paediatric brachytherapy, miscellaneous
Digital Poster
Brachytherapy
General brachytherapy
Digital Poster
Brachytherapy
Gynaecology
Digital Poster
Brachytherapy
Head & neck, skin, eye
Digital Poster
Brachytherapy
Physics
Digital Poster
Brachytherapy
Urology - prostate, bladder, penis
Digital Poster
Brachytherapy
Biomarkers
Digital Poster
Clinical
Breast
Digital Poster
Clinical
CNS
Digital Poster
Clinical
Gynaecological
Digital Poster
Clinical
Haematology
Digital Poster
Clinical
Head & neck
Digital Poster
Clinical
Lower GI
Digital Poster
Clinical
Lung
Digital Poster
Clinical
Mixed sites/palliation
Digital Poster
Clinical
Paediatric tumours
Digital Poster
Clinical
Sarcoma/skin cancer/malignant melanoma
Digital Poster
Clinical
Upper GI
Digital Poster
Clinical
Urology
Digital Poster
Clinical
Education in radiation oncology
Digital Poster
Interdisciplinary
Global health
Digital Poster
Interdisciplinary
Health economics & health services research
Digital Poster
Interdisciplinary
Other
Digital Poster
Interdisciplinary
Autosegmentation
Digital Poster
Physics
Detectors, dose measurement and phantoms
Digital Poster
Physics
Dose calculation algorithms
Digital Poster
Physics
Dose prediction, optimisation and applications of photon and electron planning
Digital Poster
Physics
Image acquisition and processing
Digital Poster
Physics
Inter-fraction motion management and offline adaptive radiotherapy
Digital Poster
Physics
Intra-fraction motion management and real-time adaptive radiotherapy
Digital Poster
Physics
Machine learning models and clinical applications (excluding imaging and segmentation)
Digital Poster
Physics
Optimisation, algorithms and applications for ion beam treatment planning
Digital Poster
Physics
Quality assurance and auditing
Digital Poster
Physics
Radiomics, functional and biological imaging and outcome prediction
Digital Poster
Physics
Immuno-radiobiology
Digital Poster
Radiobiology
Microenvironment
Digital Poster
Radiobiology
Normal tissue radiobiology
Digital Poster
Radiobiology
Tumour radiobiology
Digital Poster
Radiobiology
Patient care, preparation, immobilisation and IGRT verification protocols
Digital Poster
RTT
Patient experience and quality of life
Digital Poster
RTT
RTT education, training, advanced practice and role developments
Digital Poster
RTT
RTT service evaluation, quality assurance and risk management
Digital Poster
RTT
RTT treatment planning, OAR and target definitions
Digital Poster
RTT
+(event:"a7b130b7-ab19-ef11-9f89-000d3ab97e6f")